Proteomic Profiling of Undifferentiated hBM Mesenchymal Stem Cells under High Glucose Conditions
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Mi-Ryung | - |
dc.contributor.author | Choi, Ae-Jin | - |
dc.contributor.author | Kim, Chan-Wha | - |
dc.date.accessioned | 2021-09-08T10:59:25Z | - |
dc.date.available | 2021-09-08T10:59:25Z | - |
dc.date.issued | 2009-12 | - |
dc.identifier.issn | 1738-2696 | - |
dc.identifier.issn | 2212-5469 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/118802 | - |
dc.description.abstract | Bone marrow mesenchymal stem cells (BM-MSCs) have been suggested to participate in the physiologic healing process of tissue injury by being recruited from the bone marrow and home into the injured site through circulation. To investigate the effect of diabetic hyperglycemia on circulating BM MSCs, which would affect their differentiation, two-dimensional electrophoresis (2-DE) was performed to determine the pattern of protein expression in BM MSCs. After exposure to high (25 mM) glucose concentration for 3 days, six proteins were found to be down regulated by less than 50% (ERp29, Triosephosphate, ATP synthase, phosphoprotein enriched in asprocytes 15, putative glycogen phosphorylase and myosin light chain 3) relative to the control. In addition, 2 proteins (LPLUNC1, isoAsp carboxyl methyltransferase) were neo expressed and one (beta-galactoside binding lectin) protein was shown to be up regulated by more than 300% as a result of hyperglycemia. These results may provide a framework for understanding the molecular mechanism and relationship between hyperglycemia and stem cells. | - |
dc.format.extent | 9 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | KOREAN TISSUE ENGINEERING REGENERATIVE MEDICINE SOC | - |
dc.title | Proteomic Profiling of Undifferentiated hBM Mesenchymal Stem Cells under High Glucose Conditions | - |
dc.type | Article | - |
dc.publisher.location | 대한민국 | - |
dc.identifier.scopusid | 2-s2.0-84884538963 | - |
dc.identifier.wosid | 000273647500005 | - |
dc.identifier.bibliographicCitation | TISSUE ENGINEERING AND REGENERATIVE MEDICINE, v.6, no.14, pp 1366 - 1374 | - |
dc.citation.title | TISSUE ENGINEERING AND REGENERATIVE MEDICINE | - |
dc.citation.volume | 6 | - |
dc.citation.number | 14 | - |
dc.citation.startPage | 1366 | - |
dc.citation.endPage | 1374 | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART001414846 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kciCandi | - |
dc.relation.journalResearchArea | Cell Biology | - |
dc.relation.journalResearchArea | Engineering | - |
dc.relation.journalWebOfScienceCategory | Cell & Tissue Engineering | - |
dc.relation.journalWebOfScienceCategory | Engineering, Biomedical | - |
dc.subject.keywordPlus | VEIN ENDOTHELIAL-CELLS | - |
dc.subject.keywordPlus | PANCREATIC BETA-CELLS | - |
dc.subject.keywordPlus | BONE-MARROW | - |
dc.subject.keywordPlus | INDUCED APOPTOSIS | - |
dc.subject.keywordPlus | PROGENITOR CELLS | - |
dc.subject.keywordPlus | MESANGIAL CELLS | - |
dc.subject.keywordPlus | END-PRODUCTS | - |
dc.subject.keywordPlus | PROTEIN | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordPlus | MITOCHONDRIA | - |
dc.subject.keywordAuthor | hBM-MSCs | - |
dc.subject.keywordAuthor | hyperglycemia | - |
dc.subject.keywordAuthor | 2-DE | - |
dc.subject.keywordAuthor | proteome | - |
dc.subject.keywordAuthor | diabetes | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.